Corporate Fp&a

**About Aqemia** **About the team you’ll join **\uD83E\uDD3C‍ ️ We are seeking a corporate FP&A to lead and optimize the financial performance of Aqemia. In this key role, you will oversee financial reporting, budgeting, and forecasting, driving strategic insights and supporting decision-making across the company. You will work directly with Théa, our Head of Finance, who brings deep expertise in financial modeling and corporate finance (ex-Morgan Stanley). As the first hire on Aqemia’s growing finance team, you will have significant opportunities to expand your skillset and shape the future of our financial operations. This is just the beginning of a long and exciting journey Your contributions will be instrumental in delivering insightful management reports to our leadership team, empowering them to make informed and strategic decisions. **Your role as a Corporate FP&A at Aqemia \uD83D\uDC69\uD83C\uDFFC‍\uD83D\uDCBB**: - Fully responsible for developing financial projections to support strategic decision-making and deliver accurate performance indicators with the ultimate goal of enhancing Aqemia's business plan - Monitor and identify operational costs for Aqemia’s drug discovery programs to help us opting for the best portfolio strategy - Identify and analyze key business drivers and KPIs through competition monitoring to optimize company’s performance - Prepare and analyze monthly and quarterly reports to leadership team - Prepare external financial communication to investors and Board - Collaborate with other departments (drug discovery program leaders, managers of the wet lab outsourcing, HRs, tech) to gather financial data and insights: become a real business partner **The competencies we are looking for \uD83D\uDD0D**: - Fluent in English - Master’s Degree in Finance/Management field - Proven experience in Banking, Audit or Transaction Services (5 years minimum) - Very strong skills in accounting and finance (including solid financial modelling skills) - Business-oriented profile and attention to detail required - Strong communication skills with the ability to synthesize data and complex information, and present succinctly to executives and stakeholders at all levels - Highly organized, flexible and easily adaptive to changing conditions - Previous experience in a deep-tech and/or fast-paced start-up is a plus Preferred mindset - You are eager to play an active role in contributing to Aqemia’s strategy to develop drugs for patients - You are motivated to bring your wealth of knowledge and skills to the table - You are keen to solve tough problems on issues that truly matter, with a proactive and a can-do attitude - You are curious and you want to learn new things to put yourself outside of your comfort zone: learn more about finance, drug discovery and AI **Our recruitment process \uD83E\uDD1D**: - 1- Qualification call: Théa - 1 - Hiring Manager’s interview including business case: you will meet with your future manager Théa in person - 2 - Cultural fit interview with our co-founder and COO Emmanuelle - 3 - Final interview with our co-founder and CEO Maximilien **About us** - We work for a mission: joining us means having your own impact on changing the way drugs are discovered, and helping to shape the direction of our fast-growing company and team._ \uD83D\uDE80** Mission-Driven**:We want to find many drugs and change drug discovery paradigm \uD83D\uDC8A** Fast-growing drug discovery pipe and proofs: Internal pipeline** with multiple programs against cancer for now, most advanced ones currently in vivo proof of concept/ patent stage + **Collaborations** with several top Pharma companies such as Sanofi, J&J (...) incl. 140M$ deal with Sanofi \uD83D\uDC65 **Interdisciplinary world-Class team**:built a team of 60 top tier people at the crossroads of tech and life sciences \uD83D\uDC64** Experienced Founders**:15+ years experience including resp. leading research at ENS, Oxford, Cambridge and career in strategy con>sulting at BCG. \uD83D\uDCAB **DeepTech Innovators**: Part of the French Tech 120 and France 2030, spinoff of Ecole Normale Superieure and CNRS \uD83C\uDFE2 **Prime Location**: Paris (1 Bd Pasteur) with 2 days of remote per week. \uD83C\uDF0E** International environment**:Our working language is English. We offer a relocation package for those who wish to join us in France, which includes assistance in finding an apartment, help with all administrative tasks, and optional French lessons. \uD83D\uDCB8 **Fundraising**: $60M with European tech/deeptech funds - Elaia Partners (French leader deeptech VC), Eurazeo (largest European investment fund), Bpifrance Large Venture (largest French fund and fund of funds) and Wendel (PE tech fund).